Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study
Clinical trial NCT05718869 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05718869
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-18
- Primary completion
- 2026-09-08
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.